Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | ANNUAL REPORT | f10k2021_allaritytherap.htm iXBRL | 10-K | 3466729 |
| 2 | DESCRIPTION OF CAPITAL STOCK | f10k2021ex4vi_allarity.htm | EX-4.VI | 21999 |
| 3 | ASSIGNMENT AND ASSUMPTION AGREEMENT BETWEEN ALLARITY THERAPEUTICS, INC. AND ALLA | f10k2021ex10-17_allarity.htm | EX-10.17 | 15910 |
| 4 | EXCLUSIVE LICENSE AGREEMENT WITH ONCOHEROES BIOSCIENCE, INC. DATED JANUARY 2, 20 | f10k2021ex10-18_allarity.htm | EX-10.18 | 365518 |
| 5 | EXCLUSIVE LICENSE AGREEMENT WITH ONCOHEROES BIOSCIENCE, INC. DATED JANUARY 2, 20 | f10k2021ex10-19_allarity.htm | EX-10.19 | 421623 |
| 6 | AMENDED AND RESTATED LICENSE AGREEMENT AMONG ALLARITY THERAPEUTICS EUROPE APS, L | f10k2021ex10-20_allarity.htm | EX-10.20 | 178855 |
| 7 | SUPPORT AGREEMENT BETWEEN ALLARITY THERAPEUTICS A/S AND LIPLASOME PHARMA APS, DA | f10k2021ex10-21_allarity.htm | EX-10.21 | 45496 |
| 8 | SUBSIDIARIES OF THE REGISTRANT | f10k2021ex21-1_allarity.htm | EX-21.1 | 4749 |
| 9 | CERTIFICATION | f10k2021ex31-1_allarity.htm | EX-31.1 | 11604 |
| 10 | CERTIFICATION | f10k2021ex31-2_allarity.htm | EX-31.2 | 11472 |
| 11 | CERTIFICATION | f10k2021ex32-1_allarity.htm | EX-32.1 | 5391 |
| 12 | CERTIFICATION | f10k2021ex32-2_allarity.htm | EX-32.2 | 5014 |
| 13 | GRAPHIC | image_001.jpg | GRAPHIC | 28145 |
| 14 | GRAPHIC | image_002.jpg | GRAPHIC | 28145 |
| 15 | GRAPHIC | image_003.jpg | GRAPHIC | 94498 |
| 16 | GRAPHIC | image_004.jpg | GRAPHIC | 88321 |
| 17 | GRAPHIC | image_005.jpg | GRAPHIC | 60551 |
| 18 | GRAPHIC | image_006.jpg | GRAPHIC | 93547 |
| 19 | GRAPHIC | image_007.jpg | GRAPHIC | 125545 |
| 20 | GRAPHIC | image_008.jpg | GRAPHIC | 84324 |
| 21 | GRAPHIC | image_009.jpg | GRAPHIC | 38165 |
| 22 | GRAPHIC | image_010.jpg | GRAPHIC | 38165 |
| 23 | GRAPHIC | image_011.jpg | GRAPHIC | 63161 |
| 24 | GRAPHIC | image_012.jpg | GRAPHIC | 79792 |
| 25 | GRAPHIC | image_013.jpg | GRAPHIC | 82509 |
| 26 | GRAPHIC | image_014.jpg | GRAPHIC | 68098 |
| 27 | GRAPHIC | image_015.jpg | GRAPHIC | 90164 |
| 28 | GRAPHIC | image_016.jpg | GRAPHIC | 73654 |
| 29 | GRAPHIC | image_017.jpg | GRAPHIC | 62246 |
| 30 | GRAPHIC | image_018.jpg | GRAPHIC | 66707 |
| 31 | GRAPHIC | image_019.jpg | GRAPHIC | 53839 |
| 32 | GRAPHIC | image_020.jpg | GRAPHIC | 55908 |
| 33 | GRAPHIC | image_021.jpg | GRAPHIC | 37454 |
| 34 | GRAPHIC | image_022.jpg | GRAPHIC | 37155 |
| 35 | GRAPHIC | image_023.jpg | GRAPHIC | 74932 |
| 36 | GRAPHIC | image_024.jpg | GRAPHIC | 25167 |
| 37 | GRAPHIC | image_025.jpg | GRAPHIC | 30172 |
| 38 | GRAPHIC | image_026.jpg | GRAPHIC | 33430 |
| 39 | GRAPHIC | image_030.jpg | GRAPHIC | 17086 |
| 40 | GRAPHIC | image_031.jpg | GRAPHIC | 19954 |
| 41 | GRAPHIC | image_032.jpg | GRAPHIC | 25638 |
| 42 | GRAPHIC | image_033.jpg | GRAPHIC | 28611 |
| 43 | GRAPHIC | image_034.jpg | GRAPHIC | 19636 |
| Complete submission text file | 0001213900-22-027311.txt | 17622196 |
Data Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 44 | XBRL SCHEMA FILE | allr-20211231.xsd | EX-101.SCH | 133780 |
| 45 | XBRL CALCULATION FILE | allr-20211231_cal.xml | EX-101.CAL | 40889 |
| 46 | XBRL DEFINITION FILE | allr-20211231_def.xml | EX-101.DEF | 487069 |
| 47 | XBRL LABEL FILE | allr-20211231_lab.xml | EX-101.LAB | 931439 |
| 48 | XBRL PRESENTATION FILE | allr-20211231_pre.xml | EX-101.PRE | 512131 |
| 158 | EXTRACTED XBRL INSTANCE DOCUMENT | f10k2021_allaritytherap_htm.xml | XML | 1207093 |
IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41160 | Film No.: 22931661
SIC: 2834 Pharmaceutical Preparations
